摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3,4-二甲氧基苯乙基)乙酰胺 | 6275-29-2

中文名称
N-(3,4-二甲氧基苯乙基)乙酰胺
中文别名
——
英文名称
N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide
英文别名
N-(3,4-dimethoxyphenethyl)acetamide;N-Acetylhomoveratrylamine
N-(3,4-二甲氧基苯乙基)乙酰胺化学式
CAS
6275-29-2
化学式
C12H17NO3
mdl
MFCD00179923
分子量
223.272
InChiKey
WEQRLEDPPGQGOP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    57.5-59 °C
  • 沸点:
    225-230 °C(Press: 10 Torr)
  • 密度:
    1.067±0.06 g/cm3(Predicted)
  • 保留指数:
    1978

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    16
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.416
  • 拓扑面积:
    47.6
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2924299090

SDS

SDS:c80e0e3e7d64f78326db7c7439438907
查看

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : N-(2-(3,4-DIMETHOXY-PHENYL)-ETHYL)-
ACETAMIDE
CAS-No. : 6275-29-2
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Eye irritation (Category 2)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Irritating to eyes.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram
Signal word Warning
Hazard statement(s)
H319 Causes serious eye irritation.
Precautionary statement(s)
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s)
R-phrase(s)
R36 Irritating to eyes.
S-phrase(s)
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
Other hazards - none

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C12H17NO3
Molecular Weight : 223,27 g/mol
Component Concentration
N-(2-(3,4-DIMETHOXY-PHENYL)-ETHYL)-ACETAMIDE
CAS-No. 6275-29-2 -

Section 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly
investigated.
Indication of any immediate medical attention and special treatment needed
no data available

Section 5. FIRE-FIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end uses
no data available

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at
the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested and
approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the
standard EN 374 derived from it.
Body Protection
impervious clothing, The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges. Use
respirators and components tested and approved under appropriate government standards such as
NIOSH (US) or CEN (EU).

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 1,115
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes Causes serious eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly
investigated.
Additional Information
RTECS: Not available

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    描述:
    N-(3,4-二甲氧基苯乙基)乙酰胺三溴化硼 作用下, 以 二氯甲烷 为溶剂, 反应 20.0h, 以90%的产率得到N-[2-(3,4-二羟基苯基)乙基]乙酰胺
    参考文献:
    名称:
    Synthesis, DNA Binding and Antitumor Evaluation of Styelsamine and Cystodytin Analogues
    摘要:
    一系列N-14侧链取代的styelsamine(吡啶并[4,3,2-mn]吖啶)和cystodytin(吡啶并[4,3,2-mn]吖啶-4-酮)生物碱类似物已被制备并评估其结合DNA亲和力和对人类肿瘤细胞系的抗增殖活性。总体发现styelsamine类似物是更强的DNA结合剂,天然产物styelsamine B和D具有特别高的亲和力(Kapp分别为5.33 × 10^6 M^-1和3.64 × 10^6 M^-1)。相比之下,cystodytin亚胺醌生物碱对DNA的亲和力较低,但在抑制体外肿瘤细胞增殖方面通常与styelsamine类似物一样活跃。对于多个类似物,观察到对非小细胞肺癌、黑色素瘤和肾癌细胞系的亚组选择性。观察到整个细胞活性和clogP之间的相关性,最强烈的抗增殖活性在3-苯基丙酰胺类似物37和41中观察到(NCI面板平均GI50分别为0.4 μM和0.32 μM),clogP约为4.0-4.5。
    DOI:
    10.3390/md11020274
  • 作为产物:
    参考文献:
    名称:
    Lete, Esther; Collado, M. Isabel; Sotomayor, Nuria, Journal of Heterocyclic Chemistry, 1995, vol. 32, # 6, p. 1751 - 1758
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Iodination of Alkyl Aryl Ethers by Mercury(II) Oxide-Iodine Reagent in Dichloromethane
    作者:Kazuhiko Orito、Takahiro Hatakeyama、Mitsuhiro Takeo、Hiroshi Suginome
    DOI:10.1055/s-1995-4089
    日期:1995.10
    A convenient method for selective mono- and diiodination of alkyl aryl ethers by mercury(II) oxide-iodine reagent in dichloromethane is reported.
    报道了一种在二氯甲烷中利用氧化汞(II)试剂选择性实现烷基芳基醚单化和二化的简便方法。
  • Regioselective, photochemical bromination of aromatic compounds using N-bromosuccinimide
    作者:Prakash K. Chhattise、A.V. Ramaswamy、Suresh B. Waghmode
    DOI:10.1016/j.tetlet.2007.10.126
    日期:2008.1
    Regioselective nuclear bromination of aromatic compounds is investigated with N-bromosuccinimide as the brominating agent under UV irradiation to afford the corresponding brominated compounds. The reaction proceeds at ambient temperature (30 ± 2 °C) without any catalyst. In most of the reactions, regioselectively mono-brominated products are obtained in good to high yields. The conversion and selectivity
    用N-琥珀酰亚胺作为化剂,在紫外线辐射下研究了芳香族化合物的区域选择性核化反应,得到了相应的化化合物。反应在环境温度(30±2°C)下进行,没有任何催化剂。在大多数反应中,以高产率或高产率获得区域选择性单化产物。化的转化率和选择性取决于芳环上取代基的性质。
  • Synthesis and spectroscopic studies of some hydrogenated thiazolo[2,3- a ]isoquinolines
    作者:Maria D Rozwadowska、Agnieszka Sulima
    DOI:10.1016/s0040-4020(01)00224-1
    日期:2001.4
    4-dihydroisoquinoline derivatives under the action of α-mercapto alkanoic acids or ethylene sulfide, respectively. In the synthesis of compounds 2 and 5 isothiocarbostril (13) and N-thioacetyl-β-phenylethylamine derivatives (14), respectively, were also used as substrates and treated with bromoacetic acid derivatives. Spectral characteristics (IR, 1H, 13C NMR and MS) of compounds 1–12 are presented.
    二氢-5- ħ -噻唑并[2,3-一个]异喹啉酮(1 - 6)和四氢-5- ħ -噻唑并[2,3一]异喹啉(7 - 12)已经从下3,4-二氢异喹啉生物制备α-巯基链烷酸或亚乙基的作用。在化合物2和5的合成中,异硫脲化合物(13)和N-代乙酰基-β-苯乙胺生物(14)也分别用作底物,并用溴乙酸生物处理。光谱特性(IR,1 H,给出了化合物1 – 12的13 C NMR和MS)。
  • Indium metal as a reducing agent in organic synthesis
    作者:Michael R. Pitts、Justin R. Harrison、Christopher J. Moody
    DOI:10.1039/b101712h
    日期:——
    aromatic nitro compounds under similar conditions results in selective reduction of the nitro groups; ester, nitrile, amide and halide substituents are unaffected. Likewise indium in aqueous ethanolic ammonium chloride is an effective method for the deprotection of 4-nitrobenzyl ethers and esters. Indium is also an effective reducing agent under non-aqueous conditions and α-oximino carbonyl compounds can
    的低第一电离能(5.8 eV)及其对空气和的稳定性表明,这种属元素应是有机基材的有用还原剂。使用属还原C描述了硝基化合物和共轭烯烃的亚胺中的N键,苯并稠合的氮杂环中的杂环以及4-硝基苄基保护基的去除。因此,使用乙醇氯化铵溶液中的属选择性地还原喹啉异喹啉喹喔啉中的杂环。在相似条件下处理一系列芳香族硝基化合物会导致硝基的选择性还原;酯,腈,酰胺和卤化物取代基不受影响。同样地,乙醇乙醇溶液中的是使4-硝基苄基醚和酯脱保护的有效方法。在非条件下也是有效的还原剂,α-基羰基化合物可以选择性地还原为相应的N-在乙酸酐二碳酸二叔丁酯存在下,用粉,乙酸在THF中的叔胺保护。在THF-乙酸中的也会还原共轭烯烃。
  • Copper-Catalyzed Hydroamination of Allenes: from Mechanistic Understanding to Methodology Development
    作者:Luca Alessandro Perego、Rémi Blieck、Antoine Groué、Florian Monnier、Marc Taillefer、Ilaria Ciofini、Laurence Grimaud
    DOI:10.1021/acscatal.7b00911
    日期:2017.7.7
    Experimental and theoretical mechanistic studies on the Cu(OTf)2-catalyzed hydroamination reaction of terminal allenes with secondary amines reveal that in situ generated cationic Cu(I) is the catalytically active species and explain the observed regio- and stereoselectivity for the unbranched E product. Insight into the structure of the relevant transition states allowed the generalization of this
    对末端异位烯与仲胺的Cu(OTf)2催化加氢胺化反应的实验和理论机理研究表明,原位生成的阳离子Cu(I)是催化活性物质,并解释了所观察到的对直链E产物的区域和立体选择性。对相关过渡态结构的洞察力使这种方法可以推广到前所未有的温和和耐官能团条件下的烯丙酰胺和N-烯丙基氨基甲酸酯。除电子作用外,酰胺氧的螯合作用也解释了这类底物的高固有反应性。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸